Mirae Asset Global ETFs Holdings
TARA icon

Mirae Asset Global ETFs Holdings’s Protara Therapeutics TARA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92K Sell
24,095
-6
-0% -$29 ﹤0.01% 2866
2026
Q1 		$126K Buy
24,101
+7,747
+47% +$45.9K ﹤0.01% 2571
2025
Q4 		$87.2K Buy
16,354
+1,502
+10% +$8.35K ﹤0.01% 2732
2025
Q3 		$64.6K Sell
14,852
-2,783
-16% -$9.01K ﹤0.01% 2860
2025
Q2 		$53.4K Buy
+17,635
New +$60.8K ﹤0.01% 2868

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TARA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Protara Therapeutics (TARA) stake by 0.02% in Q2 2026, selling an estimated $29 and leaving 24,095 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #2866.

Mirae Asset Global ETFs Holdings first reported a position in TARA in Q2 2025 and has held it in 5 quarters since. The position peaked at $126K in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 24,095 shares of Protara Therapeutics worth $92K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 6 Protara Therapeutics shares in Q2 2026, an estimated $29.
  • Protara Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2866 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Protara Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Protara Therapeutics position peaked at $126K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.